PEDIATRICS Vol. 58 No. 6 December 1976, pp. 917
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malan, A. F.
Right arrow Articles by Heese, H. D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malan, A. F.
Right arrow Articles by Heese, H. D. V.

Intravenous Lipid and Growth in Small Premature Infants

Atties F. Malan 1, S. C. Higgs 1, and H. De V. Heese 1

1 Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa

The article by Cashore et al.1 reporting on nutritional supplements in infants weighing less than 1,500 gm at birth is most interesting. It is remarkably similar to a study carried out in Cape Town involving 86 infants.2 Both studies used parenteral lipid, protein hydrolysate, and glucose. The lipid (Intralipid, 10%) and protein hydrolysate (Amigen) were identical solutions. The purpose of this letter is to point out that comparable growth rates were achieved in both studies.